Healthcare -
Biotechnology - NASDAQ - US
$ 1.15
0.877 %
$ 152 M
Market Cap
-0.41
P/E
RAPT - COST OF REVENUE
Cost of Revenue RAPT - RAPT Therapeutics, Inc.
3.55 M
LAST VALUE
88.82%
2 YEAR CAGR
23.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR